Young-Onset Colorectal Cancer

Phase

N/A

Condition

Colon Cancer

Colorectal Cancer

Rectal Cancer

Treatment

Questionnaire Administration

Biospecimen Collection

Medical Chart Review

Clinical Study ID

NCT02863107

PA11-0566

NCI-2020-07462

Ages 18-80
All Genders
Accepts Healthy Volunteers

Study Summary

This study investigates the genetic factors that may influence the risk of developing colorectal cancer at a young age. Finding genetic markers for colorectal may help identify patients who are at risk of colorectal cancer. Studying individuals and families at high risk of cancer may help identify cancer genes and other persons at risk.

Eligibility Criteria

Inclusion

Inclusion Criteria:

PATIENTS: MDACC patients who have adenocarcinoma of the colon or rectum, diagnosed between ages 18 through 50 (young-onset), or diagnosed at age 51 through 80 (later-onset)
PATIENTS: Patient must have sufficient command of the English language and mental capacity to provide consent
FAMILY MEMBERS: Be a parent, sibling or child (first degree blood relative) of a registered MDACC patient meeting eligibility criteria above
FAMILY MEMBERS: Have sufficient command of the English language and mental capacity to provide consent
FAMILY MEMBERS: Family member must be at least 18 years of age at the time of study registration

Study Design

Questionnaire Administration

June 07, 2012

August 31, 2030

Study Description

PRIMARY OBJECTIVES:

I. To define the clinical phenotype of young-onset versus (vs.) later onset colorectal cancer (CRC), including clinicopathologic characteristics, tumor molecular markers, family history, and associated lifestyle/environmental factors.

II. To examine germline genetic alterations in patients with young-onset (diagnosed between age 18 and 50), CRC and those of their first-degree relatives, in comparison to those in patients with later-onset (diagnosed at age 51 or older) CRC.

III. To determine the frequency of the mutations and pattern of inheritance of the mutations identified above in this patient population.

IV. To correlate molecular findings to clinical endpoints of survival and disease recurrence and/or progression in patients with young-onset vs. later-onset CRC.

V. To compare the treatments received by patients with young-onset vs. later-onset CRC and their subsequent survivorship experiences.

OUTLINE:

PATIENTS: Patients complete questionnaires over 30-50 minutes about work, family history, medical history, health habits, and experience as a cancer survivor (quality of life, well-being, concerns, types of health care, and follow-up care received). Active patients, who have undergone treatment at MD Anderson Cancer Center within the past year, complete additional questionnaires at enrollment, 6 months, 12 months after treatment completion, and then every years for up to 6 years. Also, active patients who are consented to the study more than 5 years from surgery, they may complete the survivorship questionnaire once. Patients medical records are also reviewed.

FAMILY MEMBERS: Participants complete questionnaires over 10-15 minutes. Participants also undergo collection of blood or saliva samples once.

Connect with a study center

MD Anderson in The Woodlands
Conroe, Texas 77384
United States
Site Not Available
M D Anderson Cancer Center
Houston, Texas 77030
United States
Site Not Available
MD Anderson West Houston
Houston, Texas 77079
United States
Site Not Available
MD Anderson League City
League City, Texas 77573
United States
Site Not Available
MD Anderson in Sugar Land
Sugar Land, Texas 77478
United States
Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.